Characterization of cephalosporin-resistant clinical Enterobacteriaceae for CTX-M ESBLs in Bahrain  by Shahid, Mohammad et al.
S212
Document heading          doi: 10.1016/S1995-7645(14)60234-0
Characterization of cephalosporin-resistant clinical Enterobacteriaceae 
for CTX-M ESBLs in Bahrain 
Mohammad Shahid1,2,3*, Ali Al-Mahmeed1, Mariam Mumtaz Murtadha1, Ahmed Qareeballa1, Muhallab Abdulrahman 
Eltahir1, Khaled Saeed Tabbara1, Abdulrahman Yusuf Ismaeel1, Fazal Karim Dar1, Hayder Ahmed Giha1, Khalid Mubarak 
Bindayna1,4
1College of Medicine & Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain
2King Hamad University Hospital, Busaiteen, Kingdom of Bahrain
3Section of Antimicrobial Agents & Drug Resistance Research and Molecular Biology, Department of Medical Microbiology, Jawaharlal Nehru 
Medical College & Hospital, Aligarh Muslim University, Aligarh-202002, Uttar Pradesh, India
4Microbiology Section, Salmaniya Medical Complex, Manama, Kingdom of Bahrain
Asian Pac J Trop Med 2014; 7(Suppl 1): S212-S216
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
    *Corresponding author: Dr. M. Shahid, MBBS, MD, PhD, FNZIMLS, Affiliate Royal 
College of Pathologist, Australasia; Associate Professor & Consultant Microbiologist, 
Department of Microbiology & Infectious Diseases, College of Medicine & Medical 
Sciences, Arabian Gulf University, Manama, Bahrain.
     Tel: +973-17239537, 00973-36402741
     E-mail: shahidsahar@yahoo.co.in, mohammeds@agu.edu.bh
     Foundation Project: Supported by Research and Ethics Committee and the College of 
Medicine & Medical Sciences, Arabian Gulf University (Grant No. 94).
1. Introduction
   The variants of CTX-M extended-spectrum β-lactamases 
(ESBLs) have now been circulating for more than 2 decades 
since its first appearance in 1990[1]. Currently these CTX-M-
types are approaching 150 in number (CTX-M-1 to CTX-M-
151), however, few CTX-Ms such as CTX-M-14 and CTX-M-
18, CTX-M-55 and CTX-M-57, CTX-M-2 and CTX-M-97, and 
CTX-M-3 and CTX-M-133 were reported as identical (http://
www.lahey.org/Studies/other.asp#table1; last accessed)[2]. 
The increasing use of successive generations of β-lactam 
antibiotics has put a selective pressure on the bacterial 
population to produce numerous β-lactamases, including 
the CTX-M ESBLs and thus leading to resistance against 
cephalosporins[3]. This rising resistance to the third- and 
fourth-generation cephalosporins has forced to increase 
the use of carbapenems in clinical settings. However, due 
to the increasing usage of carbapenems in recent years, the 
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resistance to this group of antibiotics has also appeared[3,4]. 
   In response to the global call towards the rising threat 
of antimicrobial resistance (AMR), emphasis is now being 
put on development of surveillance programs in individual 
countries. To that end, regional scientific studies are badly 
needed, especially the research studies addressing the 
issues of AMR at a molecular level.
   While performing a careful search of literature on PubMed, 
we could get only one molecular study from Bahrain[5], 
which too didn’t characterize the genogroups (CTX-M 
clusters) or the genotypes (CTX-M types) of this important 
class of ESBLs, the CTX-M ESBL. Therefore, we planned this 
extensive molecular study to characterize the Bahraini 
Enterobacteriaceae for the presence of specific genogroups 
and genotypes of CTX-M enzymes.
2. Materials and methods
2.1. Bacterial isolates 
   The bacterial cohort comprised of 80 Enterobacteriaceae 
isolates [75 Escherichia coli (E. coli) and 5 Klebsiella 
pneumoniae (K. pneumoniae)] that were previously tested 
for the presence of CTX-M genes by using the general set 
of primers; the isolates were not characterized for CTX-M 
genogroups or the CTX-M types in that study[5]. These 
isolates were collected from a 1 000-bed secondary care 
hospital, Salmaniya Medical Complex, from Bahrain during 
the period 1st January to 30th June 2006. 
2.2. Molecular characterization
   Molecular studies were carried out in the Department of 
Microbiology, Immunology & Infectious Diseases (DMIID) 
of the College of Medicine & Medical Sciences of Arabian 
Gulf University, Bahrain. The isolates were subjected to 
multiplex- and monoplex-PCR reactions according to the 
protocol described elsewhere[6]. The sets of primers used 
for the multiplex PCR were of the following genogroups: 
blaCTX-M group-1, blaCTX-M group-2, blaCTX-M group-8, blaCTX-M 
group-9 and blaCTX-M group-25. The details of the primers 
used and the expected amplicons sizes of the respective 
CTX-M genogroups are shown in Table 1. Following cycling 
conditions were used for the detection of blaCTX-M genogroups 
by multiplex-PCR: initial denaturation at 94 °C for 5 min, 
followed by 40 cycles of denaturation at 94 °C for 1 min, 
annealing at 52 °C for 60 seconds, initial extension at 72 
°C for 1 min and with a final extension at 72 °C for 10 min. 
For blaCTX-M monoplex-PCR the cycling conditions were: 
initial denaturation at 94 °C for 7 min, followed by 35 cycles 
consisting of 94 °C for 50 seconds, 50 °C for 40 seconds and 
72 °C for 2 min and a final elongation at 72 °C for 5 min.
   The isolates found positive for any multiplex-PCR 
reaction were classified into the genogroups based on the 
amplicon sizes and were further subjected to a monoplex-
PCR reaction for confirmation using the sets of primers of 
the respective genogroups. In the isolates where multiple 
bands corresponding to different genogroups were noticed, 
they were subjected to separate monoplex-PCR reactions 
using the respective primer sets.
Table 1
The list of primers used for multiplex- and monoplex-PCRs and the expected 
amplicons.
Target gene Primer used Primer sequence Amplicon 
size
blaCTX-M group-1 CTX-M gp1F 5’-AAA AAT CAC TGC GCC AGT TC-3’ 415 bp
CTX-M gp1R 5’-AGC TTA TTC ATC GCC ACG TT-3’
blaCTX-M group-2 CTX-M gp2F 5’-CGA CGC TAC CCC TGC TAT T-3’ 552 bp
CTX-M gp2R 5’-CCA GCG TCA GAT TTT TCA GG-3’
blaCTX-M group-9 CTX-M gp9F 5’-CAA AGA GAG TGC AAC GGA TG-3’ 205 bp
CTX-M gp9R 5’-ATT GGA AAG CGT TCA TCA CC-3’
blaCTX-M group-8 CTX-M gp8F 5’-TCG CGT TAA GCG GAT GAT GC-3’ 666 bp
blaCTX-M group-25 CTX-M gp25F 5’-GCA CGA TGA CAT TCG GG-3’ 327 bp
*
CTX-M gp8/25R 5’-AAC CCA CGA TGT GGG TAG C-3’
*: This primer was used as a reverse primer for genogroup-8 and genogroup-25.
2.3. Sequencing of the bla genes from representative isolates
   Once the bla genes were characterized into CTX-
genogroups based on multiplex- and monoplex-PCR 
experimentations, representative isolates from the 
different CTX-M genogroups were further subjected for 
sequencing experimentations in order to identify the CTX-M 
genotypes. The amplicons were subjected to purification 
experimentation at DMIID and further submitted to 
Genoscreen, France for sequencing. The primers used in 
the monoplex-PCR for respective genogroups were used 
for the sequencing reactions. The sequence results thus 
obtained from the Genoscreen were analyzed at DMIID by 
using the Chromas software (http://technelysium.com.
au/)[7], and the basic local alignment search tool (BLAST) 
search engine. Further alignment was performed against 
the specific CTX-M-types by using the Clustal W software 
(http://www.genome.jp/tools/clustalw/)[8]. 
3. Results
   In multiplex-PCR, a total of 93.8% (75/80) showed the 
amplicons corresponding to any of the CTX-M genogroups 
(1, 2, 8, 9, and 25) and the remaining 5 (6.2%) isolates turned 
out negative despite repeated attempts. Seventy E. coli, out 
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of 75 isolates, showed the amplicons in PCR while 5 isolates 
didn’t show any. All the 5 K. pneumoniae isolates showed 
amplicons in the PCR reactions. Some of the isolates 
demonstrated multiple bands corresponding to the sizes 
of different genogroups. The detailed results are shown in 
Figure 1.  
 1      2      3      4      5      6      7      M    8      9    10    11    12   13    14
 1      2      3      4      5      6      7      8     M     9    10    11    12   13    14
 1      2      3      4      5      6      7    8      M     9    10    11    12   13    14
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Figure 1. Representative gels showing the results of multiplex PCR. 
A: Lanes 1, 3-7, 9, 11-14 show amplicons of 415 bp corresponding to CTX-M 
genogroup-1; Lane 2 shows amplicon of 552 bp corresponding to CTX-M 
genogroup-2; Lanes 8 and 10 show amplicons of 205 bp corresponding to CTX-M 
genogroup-9. B: Lanes 1, 3, 4, 7-10, 12, 14 demonstrate amplicons of 415 bp 
corresponding to CTX-M genogroup 1; Lanes 4, 5 and 13 show amplicons of 205 bp 
corresponding to CTX-M genogroup 9, kindly note that lane 4 shows 2 amplicons 
of multiplex PCR (415 bp and 205 bp) corresponding to CTX-M genogroup-1 and 
CTX-M genogroup-9. C: Lanes 2-9 and 11, 12 show amplicon of 415 bp for CTX-M 
genogroup-1; Lane 13 shows multiple bands and lanes 1 and 14 were negative 
(nonspecific amplification). Lane M in the gels demonstrates 100 bp ladder.
3.1. Determination of blaCTX-M genogroups by PCR
   The isolates were grouped into genogroups according to 
the respective amplicons sizes (kindly refer to Figure 1 and 
Table 1). Further confirmation with respective monoplex-
PCR on these 75 isolates demonstrated that 93.3% (70/75) 
harboured CTX-M genogroup-1 (Figure 2A) and 6.7% (5/75) 
harboured genogroup-9 (Figure 2C). Of the 70 CTX-M 
genogroup-1 harbouring isolates, 65 were E. coli and 5 were 
K. pneumoniae, whereas all the genogroup-9 harbouring 
isolates (n=5) were E. coli. One of the isolates that 
showed the presence of genogroup-9 also demonstrated 
the presence of  a  band corresponding to  CTX-M 
genogroup-1, however, on performing the monoplex-
PCR with genogroup-1 primers, it turned out negative for 
genogroup-1 (Figure 1B). We did not find the presence of 
genogroups-2, 8, and 25 in these isolates by monoplex PCR 
(Figure 2B).
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Figure 2. Representative gels showing the results of monoplex PCR. 
A: Representative results of the monoplex PCR done for CTX-M 
genogroup-1; B: Representative results (negative) for CTX-M genogroup 2 
and CTX-M genogroup 8 in monoplex PCRs; C: Representative results of 
monoplex PCR for CTX-M genogroup-9; Lane M in all the gels demonstrates 
100 bp ladders.
    M    2     8    10  25   28          M
3.2. Determination of CTX-M types by sequencing
   Thirteen representative isolates (10 from CTX-M 
genogroup-1 and 3 from CTX-M genogroup-9) were 
subjected for sequence analyses. On performing the BLAST 
search on isolates belonging to CTX-M genogroup-1, 100% 
similarity was found with CTX-M-15 type ESBL. Alignment of 
the sequence with a known CTX-M-15 sequence (Accession 
No. KF769131.1) showed a perfect match. The BLAST search 
on CTX-M-9 genogroup harbouring isolates showed 99% 
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similarity with CTX-M 55-type ESBL and the alignment using 
a known CTX-M-55 sequence (Accession No. KC576516.1) 
showed a perfect match.
4. Discussion
   ESBLs are the enzymes that confer resistance against 
broad-spectrum cephalosporins, including third- and 
fourth-generation cephalosporins, and aztreonam; this 
third- and fourth-generation cephalosporins resistance has 
become a major concern worldwide[3,9,10]. The wider spread 
of these ESBLs in clinical Enterobacteriaceae has posed 
a serious AMR threat during the last few decades[11]. The 
ESBL phenotypes have been reported from the Middle East 
region, including from Bahrain[12-15]. However, the studies 
characterizing the CTX-M genogroups and CTX-M-types at a 
molecular level (especially by sequencing) are fragmentary 
from this region. Moreover, there is a complete lack of such 
studies from Bahrain. 
   The CTX-M types of ESBLs are currently the widespread 
enzymes globally and its variants are continuously 
increasing in numbers, CTX-M-15 being the widely 
prevalent type[1,6,16]. CTX-M-15 has also been reported 
in few studies from Arab countries, the first description 
being from Egypt and followed by from United Arab 
Emirates, Kuwait and Saudi Arabia[12,17-20]. In the present 
study, majority of the isolates (93.3%; 70/75) were of CTX-M 
genogroup-1 and the sequencing of the representative 
isolates demonstrated the presence of CTX-M-15 type. This 
signifies that CTX-M-15 is the prevalent CTX-M type in this 
part of the world, including in Bahrain. 
   A minority of the E. coli isolates (n=5) demonstrated 
an amplicon corresponding to the CTX-M genogroup-9, 
however, sequencing of the representative isolates 
designated them as CTX-M-55-like ESBL, an enzyme 
belonging to the CTX-M-1 cluster. This discrepancy in the 
PCR and sequencing results is noteworthy and suggests 
that sequencing should always be performed to designate 
the specific CTX-M types. The CTX-M-55 was first reported 
in Enterobacteriaceae from Thailand[21], and thereafter 
this enzyme has been reported from various countries, 
most of the reports being from China[22-25]. The CTX-M-
55 is reported to differ from CTX-M-15 by a single amino 
acid substitution at position 80 (Ala80Val) and could be 
an evolutionary process due to the antibiotics selective 
pressure[22]. CTX-M-15 enzymes exert increased catalytic 
activity against cefotaxime than ceftazidime, whereas 
the CTX-M-55 enzymes have activity against both of 
these antibiotics[22]. While looking to the antibiotics data 
retrospectively, we noticed that all these 5 isolates had 
resistance against both cefotaxime and ceftazidime. We 
didn’t find any published report regarding the occurrence 
of this CTX-M type (CTX-M-55) from the Arab countries. 
The occurrence of the CTX-M-55 in this region, though 
in a smaller bacterial population, suggests the bacterial 
evolution in response to the selection pressure that could 
be a consequence of over prescription or weak enforcement 
of the existing antibiotics policies. We also wish to 
emphasize that the CTX-M-55 like bla genes have already 
emerged in Kingdom of Bahrain at least 8 years ago, as 
speculated by their presence in a bacterial collection from 
year 2006. Moreover, this pilot study also suggests a need to 
look for such genes in recent, as well as in collections prior 
to year 2006 (if available with any research group), so as to 
shed more light on their likely time of emergence and also 
the current situation.  
   In nutshell, CTX-M-15 is the prevalent ESBL in Bahraini 
Enterobacteriaceae; however, CTX-M-55 has emerged, 
though in a minor proportion. As evident from our study, 
multiplex/monoplex-PCRs alone should not be performed 
in order to report the emergence of new variant of ESBL, 
rather the results should be confirmed by sequencing. 
To the best of our knowledge, this is the first report from 
Bahrain characterizing the CTX-M genogroups of ESBLs 
and reporting the emergence of blaCTX-M-55-like gene in this 
region.
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